Do analysts rate GUTS or CNXU?

Fractyl Health presently has a consensus price target of $5.40, indicating a potential upside of 535.29%. Given Fractyl Health's stronger consensus rating and higher possible upside, analysts clearly believe Fractyl Health is more favorable than Conexeu Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fractyl Health 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Conexeu Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings & valuation, GUTS or CNXU?

Conexeu Sciences has lower revenue, but higher earnings than Fractyl Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Fractyl Health $90K 1,498.36 -$140.95M -$1.29 N/A Conexeu Sciences N/A N/A N/A N/A N/A

Is GUTS or CNXU more profitable?

Conexeu Sciences' return on equity of 0.00% beat Fractyl Health's return on equity. Company Net Margins Return on Equity Return on Assets Fractyl Health N/A -4,053.15% -96.41% Conexeu Sciences N/A N/A N/A

Does the media prefer GUTS or CNXU?

In the previous week, Fractyl Health had 7 more articles in the media than Conexeu Sciences. MarketBeat recorded 10 mentions for Fractyl Health and 3 mentions for Conexeu Sciences. Fractyl Health's average media sentiment score of 0.99 beat Conexeu Sciences' score of 0.44 indicating that Fractyl Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fractyl Health 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Conexeu Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor DCTH or GUTS?

In the previous week, Fractyl Health had 8 more articles in the media than Delcath Systems. MarketBeat recorded 10 mentions for Fractyl Health and 2 mentions for Delcath Systems. Fractyl Health's average media sentiment score of 0.99 beat Delcath Systems' score of 0.94 indicating that Fractyl Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Delcath Systems 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fractyl Health 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer CV or GUTS?

In the previous week, Fractyl Health had 8 more articles in the media than CapsoVision. MarketBeat recorded 10 mentions for Fractyl Health and 2 mentions for CapsoVision. CapsoVision's average media sentiment score of 1.32 beat Fractyl Health's score of 0.99 indicating that CapsoVision is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CapsoVision 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fractyl Health 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is ELMD or GUTS more profitable?

Electromed has a net margin of 11.34% compared to Fractyl Health's net margin of 0.00%. Electromed's return on equity of 15.71% beat Fractyl Health's return on equity. Company Net Margins Return on Equity Return on Assets Electromed 11.34% 15.71% 13.37% Fractyl Health N/A -4,053.15% -96.41%

Does the media favor ELMD or GUTS?

In the previous week, Fractyl Health had 5 more articles in the media than Electromed. MarketBeat recorded 10 mentions for Fractyl Health and 5 mentions for Electromed. Fractyl Health's average media sentiment score of 0.99 beat Electromed's score of 0.31 indicating that Fractyl Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Electromed 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Fractyl Health 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Fractyl Health (GUTS) Competitors

$0.85 0.00 (0.00%)

Closing price 06/12/2026 04:00 PM Eastern

Extended Trading

$0.86 +0.01 (+0.59%)

As of 06/12/2026 07:59 PM Eastern

Compare

GUTS vs. CLPT, CNXU, DCTH, CV, and ELMD

Should you buy Fractyl Health stock or one of its competitors? MarketBeat compares Fractyl Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Fractyl Health include ClearPoint Neuro (CLPT), Conexeu Sciences (CNXU), Delcath Systems (DCTH), CapsoVision (CV), and Electromed (ELMD). These companies are all part of the "medical equipment" industry.

How does Fractyl Health compare to ClearPoint Neuro?

ClearPoint Neuro (NASDAQ:CLPT) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

Fractyl Health has a net margin of 0.00% compared to ClearPoint Neuro's net margin of -71.57%. ClearPoint Neuro's return on equity of -140.96% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ClearPoint Neuro	-71.57%	-140.96%	-36.98%
Fractyl Health	N/A	-4,053.15%	-96.41%

ClearPoint Neuro currently has a consensus target price of $18.00, indicating a potential upside of 33.93%. Fractyl Health has a consensus target price of $5.40, indicating a potential upside of 535.29%. Given Fractyl Health's stronger consensus rating and higher probable upside, analysts clearly believe Fractyl Health is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

30.1% of ClearPoint Neuro shares are owned by institutional investors. 6.9% of ClearPoint Neuro shares are owned by insiders. Comparatively, 8.5% of Fractyl Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Fractyl Health had 9 more articles in the media than ClearPoint Neuro. MarketBeat recorded 10 mentions for Fractyl Health and 1 mentions for ClearPoint Neuro. ClearPoint Neuro's average media sentiment score of 1.87 beat Fractyl Health's score of 0.99 indicating that ClearPoint Neuro is being referred to more favorably in the media.

Company	Overall Sentiment
ClearPoint Neuro	Very Positive
Fractyl Health	Positive

ClearPoint Neuro has higher revenue and earnings than Fractyl Health. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ClearPoint Neuro	$36.97M	10.90	-$25.54M	-$1.01	N/A
Fractyl Health	$90K	1,498.36	-$140.95M	-$1.29	N/A

ClearPoint Neuro has a beta of 1.31, indicating that its stock price is 31% more volatile than the broader market. Comparatively, Fractyl Health has a beta of 2.34, indicating that its stock price is 134% more volatile than the broader market.

Summary

Fractyl Health beats ClearPoint Neuro on 9 of the 16 factors compared between the two stocks.

How does Fractyl Health compare to Conexeu Sciences?

Fractyl Health (NASDAQ:GUTS) and Conexeu Sciences (NASDAQ:CNXU) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation, institutional ownership and media sentiment.

In the previous week, Fractyl Health had 7 more articles in the media than Conexeu Sciences. MarketBeat recorded 10 mentions for Fractyl Health and 3 mentions for Conexeu Sciences. Fractyl Health's average media sentiment score of 0.99 beat Conexeu Sciences' score of 0.44 indicating that Fractyl Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fractyl Health	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Conexeu Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Fractyl Health presently has a consensus price target of $5.40, indicating a potential upside of 535.29%. Given Fractyl Health's stronger consensus rating and higher possible upside, analysts clearly believe Fractyl Health is more favorable than Conexeu Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Conexeu Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Conexeu Sciences' return on equity of 0.00% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fractyl Health	N/A	-4,053.15%	-96.41%
Conexeu Sciences	N/A	N/A	N/A

Conexeu Sciences has lower revenue, but higher earnings than Fractyl Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fractyl Health	$90K	1,498.36	-$140.95M	-$1.29	N/A
Conexeu Sciences	N/A	N/A	N/A	N/A	N/A

Summary

Fractyl Health beats Conexeu Sciences on 6 of the 8 factors compared between the two stocks.

How does Fractyl Health compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability.

Delcath Systems has a net margin of 0.62% compared to Fractyl Health's net margin of 0.00%. Delcath Systems' return on equity of 0.51% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	0.62%	0.51%	0.46%
Fractyl Health	N/A	-4,053.15%	-96.41%

Delcath Systems currently has a consensus target price of $22.50, suggesting a potential upside of 91.98%. Fractyl Health has a consensus target price of $5.40, suggesting a potential upside of 535.29%. Given Fractyl Health's higher probable upside, analysts plainly believe Fractyl Health is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.43
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

61.1% of Delcath Systems shares are held by institutional investors. 19.4% of Delcath Systems shares are held by company insiders. Comparatively, 8.5% of Fractyl Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Delcath Systems has a beta of 0.54, suggesting that its share price is 46% less volatile than the broader market. Comparatively, Fractyl Health has a beta of 2.34, suggesting that its share price is 134% more volatile than the broader market.

In the previous week, Fractyl Health had 8 more articles in the media than Delcath Systems. MarketBeat recorded 10 mentions for Fractyl Health and 2 mentions for Delcath Systems. Fractyl Health's average media sentiment score of 0.99 beat Delcath Systems' score of 0.94 indicating that Fractyl Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Delcath Systems	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fractyl Health	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Delcath Systems has higher revenue and earnings than Fractyl Health. Fractyl Health is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$85.23M	4.75	$2.70M	$0.01	1,172.00
Fractyl Health	$90K	1,498.36	-$140.95M	-$1.29	N/A

Summary

Delcath Systems beats Fractyl Health on 11 of the 16 factors compared between the two stocks.

How does Fractyl Health compare to CapsoVision?

CapsoVision (NASDAQ:CV) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical equipment companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership.

CapsoVision currently has a consensus price target of $8.50, indicating a potential upside of 18.22%. Fractyl Health has a consensus price target of $5.40, indicating a potential upside of 535.29%. Given Fractyl Health's higher probable upside, analysts clearly believe Fractyl Health is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Fractyl Health has a net margin of 0.00% compared to CapsoVision's net margin of -198.87%. CapsoVision's return on equity of 0.00% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CapsoVision	-198.87%	N/A	-136.03%
Fractyl Health	N/A	-4,053.15%	-96.41%

CapsoVision has higher revenue and earnings than Fractyl Health. CapsoVision is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CapsoVision	$13.55M	26.51	-$25.32M	-$2.34	N/A
Fractyl Health	$90K	1,498.36	-$140.95M	-$1.29	N/A

In the previous week, Fractyl Health had 8 more articles in the media than CapsoVision. MarketBeat recorded 10 mentions for Fractyl Health and 2 mentions for CapsoVision. CapsoVision's average media sentiment score of 1.32 beat Fractyl Health's score of 0.99 indicating that CapsoVision is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CapsoVision	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fractyl Health	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Fractyl Health beats CapsoVision on 8 of the 14 factors compared between the two stocks.

How does Fractyl Health compare to Electromed?

Electromed (NYSE:ELMD) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, media sentiment, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Electromed has a beta of 0.53, meaning that its share price is 47% less volatile than the broader market. Comparatively, Fractyl Health has a beta of 2.34, meaning that its share price is 134% more volatile than the broader market.

Electromed currently has a consensus price target of $37.50, suggesting a potential upside of 0.97%. Fractyl Health has a consensus price target of $5.40, suggesting a potential upside of 535.29%. Given Fractyl Health's higher probable upside, analysts clearly believe Fractyl Health is more favorable than Electromed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Electromed	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Electromed has higher revenue and earnings than Fractyl Health. Fractyl Health is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Electromed	$71.75M	4.29	$5.15M	$1.17	31.74
Fractyl Health	$90K	1,498.36	-$140.95M	-$1.29	N/A

Electromed has a net margin of 11.34% compared to Fractyl Health's net margin of 0.00%. Electromed's return on equity of 15.71% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Electromed	11.34%	15.71%	13.37%
Fractyl Health	N/A	-4,053.15%	-96.41%

40.8% of Electromed shares are held by institutional investors. 10.5% of Electromed shares are held by company insiders. Comparatively, 8.5% of Fractyl Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Fractyl Health had 5 more articles in the media than Electromed. MarketBeat recorded 10 mentions for Fractyl Health and 5 mentions for Electromed. Fractyl Health's average media sentiment score of 0.99 beat Electromed's score of 0.31 indicating that Fractyl Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Electromed	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fractyl Health	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Electromed beats Fractyl Health on 11 of the 16 factors compared between the two stocks.

Get Fractyl Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GUTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GUTS vs. The Competition

Export

Metric	Fractyl Health	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$134.85M	$2.99B	$6.52B	$12.05B
Dividend Yield	N/A	1.76%	2.67%	5.66%
P/E Ratio	-0.66	18.84	24.00	24.42
Price / Sales	1,498.36	324.96	514.65	112.54
Price / Cash	N/A	55.88	27.48	37.92
Price / Book	12.14	3.98	10.69	6.82
Net Income	-$140.95M	$75.79M	$3.57B	$337.56M
7 Day Performance	26.87%	1.57%	0.61%	1.16%
1 Month Performance	-1.23%	-0.73%	1.56%	3.16%
1 Year Performance	-58.74%	23.44%	25.44%	30.60%

Fractyl Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GUTS Fractyl Health	4.4284 of 5 stars	$0.85 flat	$5.40 +535.3%	-58.7%	$134.85M	$90K	N/A	102	Gap Down High Trading Volume
CLPT ClearPoint Neuro	2.6274 of 5 stars	$13.38 +3.8%	$18.00 +34.5%	+16.5%	$386.57M	$36.97M	N/A	110	Gap Up
CNXU Conexeu Sciences	N/A	$15.27 +0.2%	N/A	N/A	$385.87M	N/A	N/A	4	Short Interest Increase Gap Up
DCTH Delcath Systems	2.7568 of 5 stars	$10.94 +2.5%	$22.50 +105.7%	-23.6%	$368.35M	$85.23M	1,094.00	60	Gap Up High Trading Volume
CV CapsoVision	1.5061 of 5 stars	$7.02 -2.4%	$8.50 +21.1%	N/A	$359.24M	$13.55M	N/A	90	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GUTS) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Fractyl Health (GUTS) Competitors

GUTS vs. CLPT, CNXU, DCTH, CV, and ELMD

How does Fractyl Health compare to ClearPoint Neuro?

Summary

How does Fractyl Health compare to Conexeu Sciences?

Summary

How does Fractyl Health compare to Delcath Systems?

Summary

How does Fractyl Health compare to CapsoVision?

Summary

How does Fractyl Health compare to Electromed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GUTS vs. The Competition

Fractyl Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Fractyl Health (GUTS) Competitors

GUTS vs. CLPT, CNXU, DCTH, CV, and ELMD

How does Fractyl Health compare to ClearPoint Neuro?

Is CLPT or GUTS more profitable?

Do analysts rate CLPT or GUTS?

Do institutionals and insiders believe in CLPT or GUTS?

Does the media favor CLPT or GUTS?

Which has better earnings and valuation, CLPT or GUTS?

Which has more volatility and risk, CLPT or GUTS?

Summary

How does Fractyl Health compare to Conexeu Sciences?

Does the media prefer GUTS or CNXU?

Do analysts rate GUTS or CNXU?

Is GUTS or CNXU more profitable?

Which has stronger earnings & valuation, GUTS or CNXU?

Summary

How does Fractyl Health compare to Delcath Systems?

Is DCTH or GUTS more profitable?

Do analysts prefer DCTH or GUTS?

Do institutionals & insiders hold more shares of DCTH or GUTS?

Which has more volatility and risk, DCTH or GUTS?

Does the media favor DCTH or GUTS?

Which has higher earnings & valuation, DCTH or GUTS?

Summary

How does Fractyl Health compare to CapsoVision?

Do analysts recommend CV or GUTS?

Is CV or GUTS more profitable?

Which has stronger earnings and valuation, CV or GUTS?

Does the media prefer CV or GUTS?

Summary

How does Fractyl Health compare to Electromed?

Which has more volatility and risk, ELMD or GUTS?

Do analysts rate ELMD or GUTS?

Which has better valuation and earnings, ELMD or GUTS?

Is ELMD or GUTS more profitable?

Do insiders & institutionals hold more shares of ELMD or GUTS?

Does the media favor ELMD or GUTS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GUTS vs. The Competition

Fractyl Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools